In the context of cancer, CXCR3 was found upregulated in many primary and metastatic tumors such as breast, prostate, colon, colorectal, melanoma and ovarian cancer, and associated with poor prognosis [20–24]. This evidence concerns the gene CXCR3 and cancer.